Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 129 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Polyzos, S. A., Toulis K. A., Goulis D. G., Zavos C., & Kountouras J. (2011).  Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.. Metabolism. 60(3), 313-26.
Polyzos, S. A., Makras P., Tournis S., & Anastasilakis A. D. (2019).  Off-label uses of denosumab in metabolic bone diseases.. Bone. 129, 115048.
Polyzos, S. A., Kountouras J., Zavos C., & Stergiopoulos C. (2010).  Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.. Med Hypotheses. 74(6), 1089-90.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Polyzos, S. A., Zeglinas C., Artemaki F., Doulberis M., Kazakos E., Katsinelos P., et al. (2018).   infection and esophageal adenocarcinoma: a review and a personal view.. Ann Gastroenterol. 31(1), 8-13.
Polyzos, S. A., Kang E. Seok, Tsochatzis E. A., Kechagias S., Ekstedt M., Xanthakos S., et al. (2020).  Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.. Metabolism. 113, 154413.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact.. Saudi J Gastroenterol. 17(6), 425-6.
Polyzos, S. A., Kountouras J., Papatheodorou A., Patsiaoura K., Katsiki E., Zafeiriadou E., et al. (2013).  Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.. Metabolism. 62(1), 121-6.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.. Metabolism. 92, 82-97.
Polyzos, S. A., Goulis D. G., Giouleme O., Germanidis G. S., & Goulas A. (2022).  Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.. Curr Obes Rep.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).
Polyzos, S. A., Singhellakis P. N., Naot D., Adamidou F., Malandrinou F. C., Anastasilakis A. D., et al. (2014).  Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene).. J Clin Endocrinol Metab. 99(3), 703-7.
Polyzos, S. A., & Terpos E. (2018).  Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis.. Endocrine. 62(2), 487-489.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.. Support Care Cancer. 17(10), 1329-30.
Polyzos, S. A., Mathew H., & Mantzoros C. S. (2015).  Irisin: A true, circulating hormone.. Metabolism. 64(12), 1611-8.
Polyzos, S. A., Kountouras J., Papatheodorou A., Katsiki E., Patsiaoura K., Zafeiriadou E., et al. (2013).  Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.. Ann Hepatol. 12(5), 749-57.
Polyzos, S. A., & Mantzoros C. S. (2020).  Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).. Metabolism. 154318.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature.. J Clin Gastroenterol. 45(1), 50-4.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Triantafyllou G. Α., & Mantzoros C. S. (2016).  Activin A and follistatin in patients with nonalcoholic fatty liver disease.. Metabolism. 65(10), 1550-8.
Polyzos, S. A., & Kountouras J. (2019).  Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology.. J Clin Gastroenterol.
Polyzos, S. A., Papaefthymiou A., Doulberis M., Mavridoglou G., & Kountouras J. (2021).  Helicobacter pylori infection and diabetes mellitus.. Diabetes Metab Syndr. 15(3), 845-846.
Polyzos, S. A., Kountouras J., Patsiaoura K., Katsiki E., Zafeiriadou E., Deretzi G., et al. (2012).  Serum homocysteine levels in patients with nonalcoholic fatty liver disease.. Ann Hepatol. 11(1), 68-76.
Polyzos, S. A., & Kountouras J. (2023).  Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?. Curr Vasc Pharmacol.
Polyzos, S. A., Kountouras J., Shields K., & Mantzoros C. S. (2013).  Irisin: a renaissance in metabolism?. Metabolism. 62(8), 1037-44.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές